Drug Type Small molecule drug |
Synonyms BGG-492, BGG-492A |
Target |
Mechanism AMPA receptor antagonists(Glutamate receptor ionotropic AMPA antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC16H19N5O4S |
InChIKeyMCECSFFXUPEPDB-UHFFFAOYSA-N |
CAS Registry912574-69-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Selurampanel | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Sclerosis | Phase 2 | - | 01 Oct 2016 | |
Muscle Spasticity | Phase 2 | - | 01 Oct 2016 | |
Migraine Disorders | Phase 2 | - | 01 May 2016 | |
Adrenocortical Adenoma | Phase 2 | US | 01 Aug 2014 | |
Adrenocortical Adenoma | Phase 2 | DE | 01 Aug 2014 | |
Adrenocortical Adenoma | Phase 2 | HU | 01 Aug 2014 | |
Adrenocortical Adenoma | Phase 2 | IT | 01 Aug 2014 | |
Adrenocortical Adenoma | Phase 2 | SK | 01 Aug 2014 | |
Adrenocortical Adenoma | Phase 2 | KR | 01 Aug 2014 | |
Endometrial Stromal Sarcoma | Phase 2 | US | 01 Aug 2014 |
NCT01302873 (Pubmed) Manual | Phase 2 | 96 | upduslssmp(tlwrtliymm) = zdtvdeivjl xkbktdkmmi (ydeemhowuu ) View more | Positive | 01 Jan 2021 | ||
Placebo | upduslssmp(tlwrtliymm) = vtkzgklgts xkbktdkmmi (ydeemhowuu ) View more | ||||||
Phase 2 | 59 | Dexamethasone Supression Test+BGG492 | asqpmczqxz(htuszrvaje) = tsinqcigyk tokjzcztqd (efbwporcwh, ahggiurbdj - yhttcjkckp) View more | - | 25 Jul 2016 | ||
Phase 2 | 75 | ftrfgrdois(matuvzjons) = cunwcfgunn ohvyifqogj (nhoputbbeb ) | - | 01 Feb 2014 | |||
ftrfgrdois(matuvzjons) = dpbmdjrcmx ohvyifqogj (nhoputbbeb ) |